• Chest · Mar 2014

    Delayed Presentation of Breast Cancer Metastatic to Solitary Fibrous Tumor of the Lung With Synchronous Contralateral Primary Non-small Cell Lung Cancer: A Case Report.

    • Frank Velez-Cubian, Robert Gabordi, Carla Moodie, and Eric Toloza.
    • Chest. 2014 Mar 1;145(3 Suppl):295A.

    Session TitleCancer Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: A solitary fibrous tumor (SFT) is a rare pleural neoplasm, and tumor-to-tumor metastases are unusual phenomena.Case PresentationA 64-year-old woman, with history of positron-emission tomography (PET)-negative invasive ductal carcinoma, Nottingham grade I, ER(+)/PR(+)/HER2(-), treated 6 years previously with cyclophosphamide and doxorubicin, then weekly paclitaxel. Upon progression, she underwent right simple and left modified radical mastectomies, with 9 of 11 left axillary lymph nodes involved by metastatic carcinoma, T1cN2aM0, followed by maintenance letrozole, which was stopped 6 months previously. She recently presented with increasing dyspnea, and imaging studies revealed a 2.9-cm, PET-positive (SUV 7.6) right lung mass and a 2.8-cm, PET-negative left lung mass. She underwent video-assisted thoracoscopic left lower lobe wedge resection, immediately followed by robotic-assisted video-thoracoscopic right upper lobectomy with mediastinal lymph node dissection. Operative (skin-to-skin) time was 267 min; estimated blood loss was 500 mL. She had no postoperative complications. The left chest tube was removed on postoperative day (POD)#1; the right chest tube was removed on POD#4. She was discharged home on POD#4. Pathology revealed a 1.4-cm x 1.3-cm x 0.8-cm right upper lobe moderately-differentiated adenocarcinoma with peripheral bronchioloalveolar pattern, T1aN0M0, stage 1A (negative resection margins) as well as a 4-cm x 3.5-cm x 1.8-cm left lower lobe pedunculated focally cystic pleural SFT containing metastatic breast ductal carcinoma, ER(+)/PR(+)/HER2(-), extending to within 0.5 mm of SFT surface and within vessels of the pseudocapsule (negative resection margins). She was placed on adjuvant fulvestrant and exemestane.DiscussionSFTs have been described as recipients for tumor-to-tumor metastases in only 5 other cases, 4 of which were synchronous with the primary donor tumor. SFTs are firm, smooth, lobulated, spindle-cell masses surrounded by capsules exhibiting rich vascularity, a characteristic shared with renal cell carcinoma, making them more suitable for harboring metastasis.ConclusionsWe present an unusual case of tumor-to-tumor metastasis involving (PET)-negative breast cancer as donor to a recipient SFT 6 years after treatment for primary breast cancer and synchronous with contralateral primary lung cancer.Reference #1: Petraki et al, International Journal of Surgical Pathology 11(2):127-135, 2003DISCLOSURE: Eric Toloza: Other: Honoraria from Intuitive Surgical Inc. for proctoring & observation site The following authors have nothing to disclose: Frank Velez-Cubian, Robert Gabordi, Prudence Smith, Shohreh Dickinson, Carla Moodie, Joseph GarrettNo Product/Research Disclosure Information.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.